14 research outputs found
On the importance of long-term functional assessment after stroke to improve translation from bench to bedside
Despite extensive research efforts in the field of cerebral ischemia, numerous disappointments came from the translational step. Even if experimental studies showed a large number of promising drugs, most of them failed to be efficient in clinical trials. Based on these reports, factors that play a significant role in causing outcome differences between animal experiments and clinical trials have been identified; and latest works in the field have tried to discard them in order to improve the scope of the results. Nevertheless, efforts must be maintained, especially for long-term functional evaluations. As observed in clinical practice, animals display a large degree of spontaneous recovery after stroke. The neurological impairment, assessed by basic items, typically disappears during the firsts week following stroke in rodents. On the contrary, more demanding sensorimotor and cognitive tasks underline other deficits, which are usually long-lasting. Unfortunately, studies addressing such behavioral impairments are less abundant. Because the characterization of long-term functional recovery is critical for evaluating the efficacy of potential therapeutic agents in experimental strokes, behavioral tests that proved sensitive enough to detect long-term deficits are reported here. And since the ultimate goal of any stroke therapy is the restoration of normal function, an objective appraisal of the behavioral deficits should be done
Validity and Reliability of Neurological Scores in Mice Exposed to Middle Cerebral Artery Occlusion
Working memory in the odor span task: effects of chlordiazepoxide, dizocilpine (MK801), morphine, and scopolamine
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
Learning behavior in rat offspring after in utero and lactational exposure to either TCDD or PCB126
Acute Morphine Treatments Alleviate Tremor in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Monkeys
Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT1A Receptor-Dependent Mechanism
The non-competitive NMDA receptor (NMDA-R) antagonist phencyclidine (PCP) - used as a pharmacological model of schizophrenia - disrupts prefrontal cortex (PFC) activity. PCP markedly increased the discharge rate of pyramidal neurons and reduced slow cortical oscillations (SCO; 0.15-4 Hz) in rat PFC. Both effects were reversed by classical (haloperidol) and atypical (clozapine) antipsychotic drugs. Here we extended these observations to mice brain and examined the potential involvement of 5-HT 2A and 5-HT 1A receptors (5-HT 2AR and 5-HT 1AR, respectively) in the reversal by clozapine of PCP actions. Clozapine shows high in vitro affinity for 5-HT 2AR and behaves as partial agonist in vivo at 5-HT 1AR. We used wild-type (WT) mice and 5-HT 1AR and 5-HT 2AR knockout mice of the same background (C57BL/6) (KO-1A and KO-2A, respectively). Local field potentials (LFPs) were recorded in the PFC of WT, KO-1A, and KO-2A mice. PCP (10 mg/kg, intraperitoneally) reduced SCO equally in WT, KO-2A, and KO-1A mice (58±4%, 42±7%, and 63±7% of pre-drug values, n = 23, 13, 11, respectively; p < 0.0003). Clozapine (0.5 mg/kg, intraperitoneally) significantly reversed PCP effect in WT and KO-2A mice, but not in KO-1A mice nor in WT mice pretreated with the selective 5-HT 1AR antagonist WAY-100635.The PCP-induced disorganization of PFC activity does not appear to depend on serotonergic function. However, the lack of effect of clozapine in KO-1A mice and the prevention by WAY-100635 indicates that its therapeutic action involves 5-HT 1AR activation without the need to block 5-HT 2AR, as observed with clozapine-induced cortical dopamine release. © 2012 American College of Neuropsychopharmacology. All rights reserved.The work leading to these results has received funding from the Innovative Medicines Initiative Joint Undertaking (IMI) under Grant Agreement No. 115008 (NEWMEDS). This work was supported by Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM) and Grants SAF 2007-62378, FIS PI09/1245 (PN de I + D + I 2008-2011, ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion), CIBERSAM (P82, 11INT3), and SENY Fundacio. PC is supported by the Researcher Stabilization Program of the Health Department of the Generalitat de Catalunya. LK was recipient of a predoctoral fellowship from the Ministry of Science and Education.Peer Reviewe